Terray Therapeutics uses NVIDIA DGX Cloud to train generative AI foundation models for small-molecule drug discovery
Terray Therapeutics · United States
Terray Therapeutics leverages NVIDIA DGX Cloud and NVIDIA Base Command Platform to train COATI, a multimodal encoder-decoder foundation model for chemistry, reducing model training time from a week to a day and improving infrastructure utilization by over 4x compared to alternate cloud services.
Overview
Terray Therapeutics leverages NVIDIA DGX Cloud and NVIDIA Base Command Platform to train COATI, a multimodal encoder-decoder foundation model for chemistry, reducing model training time from a week to a day and improving infrastructure utilization by over 4x compared to alternate cloud services.
The challenge
The chemical compound space is functionally infinite, with over 10^60 possible drug-like molecules. Typical drug discovery programs are highly inefficient and fundamentally constrained, able to explore only a few dozen to a few hundred compounds per week. When Terray was first developing COATI using a mix of on-premises GPU-based servers and traditional cloud services, provisioning and configuration of distributed training runs became increasingly challenging and tedious as models scaled up.
The solution
Terray Therapeutics leverages NVIDIA DGX Cloud and NVIDIA Base Command Platform to train COATI, a multimodal encoder-decoder foundation model for chemistry, pretrained on a dataset of hundreds of millions of small molecules, which converts chemical structures into numerical representations that can be used to generate molecules with desired properties. Terray uses a hybrid approach, training and building models on DGX Cloud and deploying and running inference on its on-prem cluster with NVIDIA RTX A6000 GPUs, drawing on dedicated NVIDIA AI experts to optimize workloads and monitor telemetry.
Reported business value
NVIDIA DGX Cloud improved infrastructure utilization by over 4x versus alternate cloud services, reduced model training time from a week to a day, and took less than one day to onboard onto DGX Cloud. Terray can now train multiple COATI variants in parallel to find the optimal pretrained embedding. Separately, integrating NVIDIA's cuEquivariance technology into Terray's proprietary TerraBind models accelerated computational performance by 3-4x and achieved an average 70% cost savings compared to PyTorch across all model sizes.
Sources
Open any source and check the claim yourself — that is the point of the register.
Other healthcare entries in the register.
Novo Nordisk builds AI drug discovery platform on Azure with Microsoft Research
Novo Nordisk partnered with Microsoft Research to build an AI platform on Azure AI and data stacks spanning regulatory affairs, early research, drug discovery and trial design, using Azure OpenAI Service, Azure Cosmos DB and Azure Kubernetes Service, with Power BI and Power Apps for collaboration. The platform includes a copilot for researchers, shared reasoning-chain templates, and governance/auditing of how data and models are used. The teams published early results on predictive AI models for cardiovascular disease risk detection, including an algorithm that Novo Nordisk says predicts patients' cardiovascular risk better than the best clinical standards, drawing on more than 100 years of insulin research data.
CDPHP modernizes infrastructure and improves medical data extraction with AWS AI/ML
CDPHP, a not-for-profit health plan serving 400,000 members in Upstate New York, used AWS services including Amazon Comprehend Medical, Amazon Textract, and Amazon SageMaker to automate its data processing pipeline for unstructured medical records and health data. The organization processed over seven million records during initial migration and now processes 3,000 electronic health records weekly. CDPHP achieved a 60% improvement in overall efficiency and reduced HEDIS report generation from 4-5 days (three data scientists) to two reports produced daily.
Mayo Clinic deploys NVIDIA DGX SuperPOD to accelerate pathology foundation models
Mayo Clinic deployed an NVIDIA DGX SuperPOD with NVIDIA DGX B200 systems to support foundation model development for pathomics, drug discovery and precision medicine. In partnership with Aignostics, Mayo Clinic built the Atlas pathology foundation model, trained on more than 1.2 million histopathology whole-slide images. The new infrastructure is reducing four weeks of pathology slide analysis work to one week.
Myriad Genetics speeds document processing with AWS GenAI Intelligent Document Processing Accelerator
Myriad Genetics partnered with the AWS Generative AI Innovation Center to replace an Amazon Textract/Comprehend pipeline with Amazon Bedrock foundation models (Nova Pro for classification, Nova Premier for extraction) using the open-source GenAI IDP Accelerator. Document classification accuracy rose from 94% to 98%, classification cost per page fell 77% (3.1 cents to 0.7 cents), and classification time fell 80% (8.5 minutes to 1.5 minutes per document). Automated key information extraction reached 90% accuracy matching the manual baseline, with a projected $132K in annual savings and 300 hours saved monthly across 9,000 prior authorizations in the Women's Health unit alone.
Was this helpful?
Your feedback helps us improve our use case database